MYC and colonic neoplasm: In the case of human colon cancer DLD-1 cells, the combination treatment reduced the expression of c-Myc and PTBP1 at both mRNA and protein levels for a longer time than seen with the T24 or 253JB-V cells, which led to profoundly greater inhibition.